AstraZeneca: News

'Poor methodology': ICMR dissociates itself from Covaxin safety study 

The Indian Council of Medical Research has disassociated itself from a Covaxin vaccine study conducted by the Banaras Hindu University (BHU).

17 May 2024


After Covishield, new study finds side effects in Covaxin recipients

A recent study published in Springer Nature revealed that over 30% of Covaxin recipients reported "adverse events of special interest" (AESI).

16 May 2024


AstraZeneca COVID vaccine linked to another rare blood clotting disorder

A new research has linked AstraZeneca's COVID-19 vaccine to an increased risk of a rare but fatal blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).

08 May 2024


AstraZeneca says it will withdraw Covid-19 vaccine globally

The United Kingdom-based pharmaceutical company, AstraZeneca, on Tuesday said that it has initiated a worldwide recall of Covid-19 vaccine.

02 May 2024


Should I be worried if I have taken AstraZeneca's Covishield?

AstraZeneca, the pharmaceutical company behind the Covishield COVID-19 vaccine, recently acknowledged the potential risk of Thrombosis with Thrombocytopenia Syndrome (TTS) as a side effect.

01 May 2024


Astrazeneca upholds vaccine safety amid health concerns

AstraZeneca has reaffirmed its dedication to patient safety amid reports of rare side effects from the AstraZeneca-Oxford COVID-19 vaccine.

30 Apr 2024


Explained: What's TTS, rare condition caused by AstraZeneca's Covishield vaccine 

In a significant development, AstraZeneca, the manufacturer of the Covishield vaccine, has acknowledged in legal documents that its vaccine may trigger a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).

AstraZeneca's antibody cocktail Evusheld effective against Omicron, finds study

AstraZeneca COVID-19 antibody cocktail, Evusheld, effectively works against the Omicron variant of coronavirus, the company said Thursday citing a lab study.

03 Dec 2021


COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective

Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.

03 Sep 2021

North Korea

Kim orders tougher virus steps after North Korea shuns vaccines

North Korean leader Kim Jong Un ordered officials to wage a tougher epidemic prevention campaign after he turned down some foreign COVID-19 vaccines offered via the UN-backed immunization program.

05 Aug 2021

Oxford University

COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll

Mattel, the maker of the Barbie doll, has created a doll to honor Professor Sarah Gilbert, who led the development of the Oxford University and AstraZeneca COVID-19 vaccine.

04 Aug 2021


India mulls mixing Covishield, Sputnik doses; no recommendation yet

India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.

17 Jul 2021


France allows visitors vaccinated with Indian-made AstraZeneca vaccine

France will now allow international travelers who have received AstraZeneca's Indian-manufactured vaccine into the country starting Sunday.

02 Jul 2021


Mix-and-match COVID-19 vaccines: What do studies say?

In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.

24 Jun 2021


Single dose of Pfizer, AstraZeneca vaccines offers 60 percent protection

A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.

Efforts on to restart AstraZeneca shipments from India: WHO official

The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of COVID-19 vaccines to countries, a senior official at the UN health agency said.

15 Jun 2021


Pfizer, AstraZeneca vaccines protect against Delta variant, says study

Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.

10 Jun 2021

COVID-19 Vaccine

AstraZeneca vaccine linked to small risk of low blood platelets

The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a small risk of developing a blood condition characterized by low platelet counts, according to a UK study.

21 May 2021


Two doses of AstraZeneca vaccine 85%-90% effective, real-world data shows

Two doses of the Oxford/AstraZeneca COVID-19 vaccine are around 85 percent to 90 percent effective against the symptomatic disease, Public Health England (PHE) has said, citing a new analysis of real-world data from the roll-out of the shot in the UK.

11 May 2021


AstraZeneca vaccine's single dose reduces death risk by 80%: Data

A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.

02 May 2021


COVID-19 vaccine formulas shouldn't be shared with India: Bill Gates

It's a terrible time to be a publicist for Bill Gates. The billionaire, who the mainstream media celebrates as a philanthropist, is being criticized for his stance on vaccine patents.

15 Apr 2021


Denmark becomes first European country to permanently drop AstraZeneca vaccine

Even as vaccines became the world's biggest hope against the highly contagious coronavirus, Denmark has stopped using the one made by British-Swedish pharma giant AstraZeneca.

AstraZeneca serves legal notice to Serum Institute over vaccine delays

Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.

03 Apr 2021

COVID-19 Vaccination

UK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients

On Saturday, the United Kingdom's medical regulator said that seven people—out of more than 18 million recipients of the Oxford-AstraZeneca jab for COVID-19 in the country—died of unusual blood clots.

02 Apr 2021

Sri Lanka

Facing delay in securing vaccines, Lanka temporarily suspends COVID-19 jabs

Sri Lanka has temporarily halted its COVID-19 vaccination program as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India (SII), a top health minister has said.

31 Mar 2021


Germany halts AstraZeneca vaccine use for under-60s over clot fears

Germany will allow general use of the AstraZeneca coronavirus vaccine only for people aged above 60 years, imposing restrictions on younger people taking the jab after several severe cases of blood clots were reported, the German government said on Tuesday.

25 Mar 2021


Amid growing cases, India temporarily halts export of AstraZeneca's vaccine

Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.

22 Mar 2021


AstraZeneca says US trial data shows vaccine 79% effective

AstraZeneca says advanced trial data from a US study on its COVID-19 vaccine shows it is 79 percent effective.

19 Mar 2021


AstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination

A chunk of European countries, that had earlier stopped using AstraZeneca's coronavirus vaccine over blood clot concerns, will resume the vaccination drive after the jab got the support of the continent's top medical regulator.

16 Mar 2021


Why European countries are halting the AstraZeneca shot

The largest and most influential European countries, like Germany, France, and Italy, have paused the rollout of coronavirus vaccine, developed by the University of Oxford and British-Swedish pharma giant AstraZeneca over blood clot fears.

13 Mar 2021


Looking at adverse effects: India on concerns over AstraZeneca vaccine

India is constantly looking at all the adverse side effects as it conducts a massive coronavirus vaccination program, a top medical expert said today.

12 Mar 2021


Use of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland

Denmark, Norway, and Iceland have temporarily suspended the use of the coronavirus vaccine developed by British-Swedish pharma giant AstraZeneca as several patients developed blood clots after getting the jab.

01 Mar 2021


AstraZeneca has sold its stake in Moderna for $1 billion

British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.

COVID-19 vaccines: SII to play huge role in mass production

British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.

WHO authorizes AstraZeneca's COVID-19 vaccine for emergency use

The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries as part of a UN-backed program to tame the pandemic.

10 Feb 2021

South Africa

South Africa scraps AstraZeneca vaccine, will give J&J jabs

South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.

04 Feb 2021


UK begins world's first alternate dosing COVID-19 vaccine trial

Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.

03 Feb 2021


Oxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study

According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.

03 Feb 2021


Russia's coronavirus vaccine approved for use in Mexico

Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.

02 Feb 2021


South Africa welcomes first delivery of COVID-19 vaccines

South Africa gave a hero's welcome on Monday to the delivery of its first COVID-19 vaccines - one million doses of the AstraZeneca vaccine produced by the Serum Institute of India.

30 Jan 2021

Narendra Modi

Sri Lanka: No adverse reactions so far following vaccination

No adverse reactions or side-effects have so far been reported by those who were vaccinated in Sri Lanka on Friday with Oxford-AstraZeneca vaccine Covishield, provided by India, health officials said on Saturday.

11 Jan 2021


Vaccine transport from SII to start from January 11/12

With the COVID-19 vaccination drive in India set to roll out on January 16, transportation of the Covishield vaccine from the Serum Institute of India's facility in Pune, is likely to start from the evening of January 11 or January 12, sources involved in logistics planning said on Sunday.

COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns

Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."

31 Dec 2020


UK's approval to Oxford-AstraZeneca vaccine paves way for India

The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.

30 Dec 2020

Oxford University

After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK

The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom.

28 Dec 2020

Oxford University

Oxford/AstraZeneca vaccine should be effective against new variant: Report

The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.

23 Dec 2020


Awaiting COVID-19 vaccine arrival, Delhi hospital working on storage facility

From installing freezers to cold chain equipment set up, arrangements are being made at a Delhi government hospital for storage of the COVID-19 vaccine, anticipating its arrival, sources said on Tuesday.

23 Dec 2020


Indian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week

The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, is likely to get approval from the Indian government for emergency use by next week, two people privy to the development told Reuters.

22 Dec 2020

Vladimir Putin

Russia, AstraZeneca to test combination of COVID-19 shots

Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.

12 Dec 2020

Times of India

Here's how the government is planning to conduct COVID-19 vaccinations

With licensing for COVID-19 vaccines expected in the coming weeks, the government has drafted a plan for vaccination campaigns.

Trial will continue: Centre on SII vaccine's "adverse reaction" claims

With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.

30 Nov 2020


SII to sue vaccine trial participant for Rs. 100 crore

The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.

26 Nov 2020


Manufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions

After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.

23 Nov 2020


Oxford's vaccine, India's best shot against coronavirus, is 70% effective

The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.

Bharat Biotech vaccine trials continued despite 'adverse event' in August

Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.

Vaccine tracker: Covishield trials running smoothly; COVAXIN expected by February

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

05 Nov 2020


Affordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla

Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.

01 Nov 2020


Vaccine tracker: Covishield expected by December; Moderna readies for launch

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

26 Oct 2020


Oxford COVID-19 vaccine generates immune response among young and old

The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.

22 Oct 2020


AstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue

A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.

20 Oct 2020


India to play crucial role in COVID-19 vaccine process

As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.

13 Oct 2020

Johnson & Johnson

Big setback: Johnson & Johnson pauses coronavirus vaccine trial

Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.

UK planning "challenge trials" that deliberately expose volunteers to COVID-19

With the world waiting for a coronavirus vaccine with bated breath, the United Kingdom is looking to launch an unusual trial — one wherein volunteers would be intentionally infected with the virus to judge how effective a vaccine is.

12 Sep 2020


AstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod

Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.

12 Sep 2020


Coronavirus: Serum Institute ordered to halt recruitment for vaccine trial

The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.

10 Sep 2020


Big setback: Serum pauses Oxford's coronavirus vaccine trial in India

A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.

10 Sep 2020

University of Oxford

Serum Institute gets notice after AstraZeneca halts coronavirus vaccine trial

Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.

09 Sep 2020

United Kingdom

AstraZeneca halts coronavirus vaccine trial after volunteer falls ill

Pharmaceutical giant AstraZeneca announced on Tuesday that it was halting late-stage trials of the coronavirus vaccine, developed in collaboration with the University of Oxford, after a volunteer fell ill.

04 Sep 2020


#VaccineTracker: Early COVID-19 vaccine results expected by September 15

As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.

27 Aug 2020

Oxford University

Coronavirus vaccine tracker: When will one be ready?

The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.

30 Jul 2020


Coronavirus: How much would the vaccines cost?

As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.

24 Jul 2020

Oxford University

Meet Adar Poonawalla, the man bringing COVID-19 vaccines to India

In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.

22 Jul 2020


As coronavirus pandemic surges, some vaccine makers expect to profit

Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.

17 Jul 2020


#GoodNews: Oxford's COVID-19 vaccine may be available by September-end

The COVID-19 vaccine developed by researchers at Oxford University in partnership with AstraZeneca generates an immune response against the infection in humans, The Telegraph reports.

07 Jun 2020


COVID-19 vaccine: What are the latest updates?

With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.